Core Insights - Adient reported revenue of $3.74 billion for the quarter ended June 2025, reflecting a year-over-year increase of 0.7% and a surprise of +5.08% over the Zacks Consensus Estimate of $3.56 billion [1] - The company's EPS for the quarter was $0.45, compared to $0.32 in the same quarter last year, although it fell short of the consensus estimate of $0.47, resulting in an EPS surprise of -4.26% [1] Company Performance Metrics - Adient's stock has returned -0.2% over the past month, while the Zacks S&P 500 composite has increased by +0.5%, indicating underperformance relative to the broader market [3] - The company holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the market in the near term [3] Light Vehicle Production Insights - Global light vehicle production reached 22.6 million, exceeding the two-analyst average estimate of 21.97 million [4] - North American light vehicle production was 4 million, surpassing the average estimate of 3.81 million [4] - Light vehicle production in Asia (excluding China) was 5.9 million, above the average estimate of 5.6 million [4] - EMEA light vehicle production was reported at 4.4 million, slightly above the average estimate of 4.35 million [4] - In China, light vehicle production was 7.6 million, exceeding the average estimate of 7.47 million [4] - South American light vehicle production was 0.7 million, slightly below the average estimate of 0.75 million [4] Net Sales Performance - Net sales in the Americas were $1.76 billion, exceeding the average estimate of $1.59 billion, with a year-over-year change of +1.3% [4] - Net sales from eliminations were reported at -$8 million, significantly better than the average estimate of -$25.92 million, representing a year-over-year change of -61.9% [4] - Net sales in Asia were $721 million, slightly below the average estimate of $739.34 million, with a year-over-year change of +1.3% [4] - EMEA net sales were $1.27 billion, above the average estimate of $1.22 billion, but showed a year-over-year decline of -1.6% [4]

Core Insights - Blue Owl Capital Corporation reported $485.84 million in revenue for the quarter ended June 2025, marking a year-over-year increase of 22.5% and exceeding the Zacks Consensus Estimate of $463.85 million by 4.74% [1] - The company's EPS for the same period was $0.40, down from $0.48 a year ago, but still above the consensus estimate of $0.39, resulting in an EPS surprise of 2.56% [1] Financial Performance Metrics - Investment income from non-controlled, non-affiliated investments showed significant growth, with interest income at $384.76 million, surpassing the average estimate of $346.72 million, reflecting a year-over-year increase of 33.9% [4] - Total investment income from non-controlled, non-affiliated investments reached $440.42 million, exceeding the average estimate of $419.91 million, representing a year-over-year change of 24.4% [4] - Investment income from controlled, affiliated investments totaled $43.75 million, slightly below the average estimate of $47.2 million, but still showing a year-over-year increase of 2.7% [4] Stock Performance - Over the past month, shares of Blue Owl Capital Corporation have returned -1.6%, contrasting with the Zacks S&P 500 composite's +0.5% change, indicating underperformance relative to the broader market [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the market in the near term [3]

Core Insights - The Pennant Group, Inc. (PNTG) reported a revenue of $219.5 million for the quarter ended June 2025, reflecting a year-over-year increase of 30.1% and surpassing the Zacks Consensus Estimate by 3.16% [1] - Earnings per share (EPS) for the quarter was $0.27, up from $0.24 in the same quarter last year, exceeding the consensus EPS estimate of $0.26 by 3.85% [1] Revenue Breakdown - Total revenue from home health and hospice services was $166.02 million, exceeding the average estimate of $162.09 million by analysts, with a year-over-year growth of 32.5% [4] - Revenue from senior living services reached $53.48 million, surpassing the two-analyst average estimate of $50.75 million, marking a year-over-year increase of 23.1% [4] - Home care and other services within home health and hospice generated $13.06 million, which was below the average estimate of $15.32 million, but still showed a significant year-over-year growth of 202.4% [4] - Hospice services revenue was $73.77 million, exceeding the average estimate of $71.57 million, with a year-over-year increase of 24.3% [4] - Home health services revenue amounted to $79.19 million, surpassing the average estimate of $75.16 million, reflecting a year-over-year growth of 28.5% [4] Stock Performance - The Pennant Group's shares have returned -14.1% over the past month, contrasting with the Zacks S&P 500 composite's increase of 0.5% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

格隆汇8月7日｜美国化妆品公司E.l.f. Beauty(ELF.US)夜盘跌超13.2%，报95.8美元。消息面上，E.l.f. Beauty公布，第二季度营收同比增长9%至3.54亿美元，略胜预期；净利润同比下降30%至3330万美元， 调整后每股盈利89美仙，高于市场预期的84美仙；毛利率下降约215个基点至69%。公司并未提供全年 收入指引，主因是新关税可能带来多种潜在后果。(格隆汇) ...

Core Insights - Ormat Technologies reported revenue of $234.02 million for the quarter ended June 2025, reflecting a year-over-year increase of 9.9% and exceeding the Zacks Consensus Estimate of $220.79 million by 5.99% [1] - The company's EPS for the quarter was $0.48, up from $0.40 in the same quarter last year, representing an EPS surprise of 29.73% against the consensus estimate of $0.37 [1] Revenue Breakdown - Product revenue reached $59.61 million, significantly higher than the estimated $44.34 million, marking a year-over-year increase of 57.7% [4] - Energy storage revenue was reported at $14.49 million, surpassing the average estimate of $12.48 million, with a year-over-year growth of 62.9% [4] - Electricity revenue was $159.91 million, slightly below the average estimate of $164.54 million, indicating a year-over-year decline of 3.8% [4] Profitability Metrics - Gross profit from product sales was $16.49 million, exceeding the average estimate of $8.97 million [4] - Gross profit from energy storage was $1.73 million, which fell short of the average estimate of $2.31 million [4] - Gross profit from electricity was reported at $38.68 million, significantly lower than the average estimate of $54.17 million [4] Stock Performance - Over the past month, Ormat Technologies' shares have returned -1.4%, contrasting with the Zacks S&P 500 composite's increase of 0.5% [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - Ingram Micro reported $12.79 billion in revenue for the quarter ended June 2025, showing no year-over-year change, with an EPS of $0.61 compared to $0 a year ago, indicating a positive earnings surprise [1] - The revenue exceeded the Zacks Consensus Estimate of $11.96 billion by 7%, while the EPS surprise was 1.67% above the consensus estimate of $0.60 [1] Financial Performance - Ingram Micro's shares have returned -6.6% over the past month, contrasting with the Zacks S&P 500 composite's +0.5% change, and the stock currently holds a Zacks Rank 5 (Strong Sell) [3] - The company’s geographic revenue breakdown includes North America at $4.98 billion, Latin America at $853.48 million, Asia-Pacific at $3.48 billion, and EMEA at $3.48 billion, all surpassing analyst estimates [4]

Core Insights - Transcat, Inc. reported revenue of $76.42 million for the quarter ended June 2025, marking a year-over-year increase of 14.6% and exceeding the Zacks Consensus Estimate of $72.43 million by 5.51% [1] - The company achieved an EPS of $0.59, up from $0.48 a year ago, representing a surprise of 47.5% compared to the consensus estimate of $0.40 [1] Revenue Breakdown - Distribution Sales reached $27.28 million, surpassing the three-analyst average estimate of $23.56 million, with a year-over-year change of 19% [4] - Service Revenue was reported at $49.14 million, slightly above the average estimate of $48.86 million, reflecting a year-over-year increase of 12.3% [4] Profit Metrics - Gross Profit from Distribution was $9.61 million, exceeding the average estimate of $7.3 million from three analysts [4] - Gross Profit from Service was reported at $16.21 million, which is close to the average estimate of $16.27 million [4] Stock Performance - Transcat's shares have returned -13.8% over the past month, contrasting with the Zacks S&P 500 composite's increase of 0.5% [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

Core Insights - MannKind reported revenue of $76.53 million for the quarter ended June 2025, reflecting a 5.7% increase year-over-year, but fell short of the Zacks Consensus Estimate by 2.58% [1] - The company's EPS was $0, a decline from $0.05 in the same quarter last year, resulting in a 100% EPS surprise compared to the consensus estimate of $0.04 [1] Revenue Breakdown - Royalties revenue was $31.23 million, exceeding the average estimate of $27.15 million, marking a year-over-year increase of 22% [4] - Revenues from collaborations and services were $22.85 million, below the estimated $30.11 million, representing a year-over-year decrease of 12.2% [4] - Commercial product sales generated $22.45 million, surpassing the estimate of $21.27 million, with an 8.1% increase compared to the previous year [4] Stock Performance - MannKind's shares have returned +10.2% over the past month, outperforming the Zacks S&P 500 composite, which saw a +0.5% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Insights - Cencora reported revenue of $80.66 billion for the quarter ended June 2025, reflecting an 8.7% increase year-over-year and surpassing the Zacks Consensus Estimate of $80.33 billion by 0.41% [1] - The company's EPS for the quarter was $4.00, up from $3.34 in the same quarter last year, exceeding the consensus EPS estimate of $3.78 by 5.82% [1] Revenue Breakdown - Total U.S. Healthcare Solutions revenue was $72.88 billion, slightly above the average estimate of $72.81 billion, marking an 8.5% year-over-year increase [4] - Total International Healthcare Solutions revenue reached $7.79 billion, exceeding the average estimate of $7.3 billion, with a year-over-year growth of 10.5% [4] - Intersegment eliminations reported at $-3.47 million, better than the estimated $-3.89 million, showing a significant year-over-year change of 63.6% [4] Stock Performance - Cencora's shares have returned -1.9% over the past month, contrasting with the Zacks S&P 500 composite's increase of 0.5% [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance against the broader market in the near term [3]

Core Insights - ViaSat reported revenue of $1.17 billion for the quarter ended June 2025, marking a 4% increase year-over-year and a surprise of +3.71% over the Zacks Consensus Estimate of $1.13 billion [1] - The company's EPS was $0.17, a significant improvement from -$0.26 in the same quarter last year, resulting in an EPS surprise of +440% compared to the consensus estimate of -$0.05 [1] Revenue Breakdown - Product revenues reached $344.68 million, exceeding the estimated $320.18 million, reflecting a year-over-year increase of +12.7% [4] - Service revenues totaled $826.37 million, slightly above the estimated $815.37 million, with a year-over-year change of +0.7% [4] - Communication Services revenue was $827.37 million, surpassing the two-analyst average estimate of $804.49 million [4] - Defense and Advanced Technologies revenue was $343.68 million, slightly below the two-analyst average estimate of $345.17 million [4] Stock Performance - ViaSat shares have returned +27.3% over the past month, significantly outperforming the Zacks S&P 500 composite's +1% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]